{"transactions":[{"id":691961,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25043,"kind":"person","name":"Liptak Vincent Paul","position":1,"cik":"0002143905","reported_name":"Liptak Vincent Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Series B Preferred Stock","published_at":"2026-08-10T22:26:05.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":22687,"ownership":{"direct":false,"nature":"By Walter T. Liptak Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a co-beneficiary and co-trustee of the Walter T. Liptak Revocable Trust (the \"Trust\") and has voting and dispositive power over the securities held by the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22687},"source":{"system":"sec-edgar","filing":"0002143905-26-000003","document":"form4-08102026_100801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000214390526000003/form4-08102026_100801.xml","form_type":"4"}},{"id":691960,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25043,"kind":"person","name":"Liptak Vincent Paul","position":1,"cik":"0002143905","reported_name":"Liptak Vincent Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-10T22:26:05.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":46561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option shall vest on August 6, 2027, and the balance of the shares shall vest in equal monthly installments over the following 36 months."}],"balance_after":46561,"derivative":{"exercise_price":16,"expiration_date":"2036-08-05","underlying":"Common Stock","underlying_shares":46561},"source":{"system":"sec-edgar","filing":"0002143905-26-000003","document":"form4-08102026_100801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000214390526000003/form4-08102026_100801.xml","form_type":"4"}},{"id":691959,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25043,"kind":"person","name":"Liptak Vincent Paul","position":1,"cik":"0002143905","reported_name":"Liptak Vincent Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-10T22:26:05.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":22687,"ownership":{"direct":false,"nature":"By Walter T. Liptak Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Preferred Stock (the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a co-beneficiary and co-trustee of the Walter T. Liptak Revocable Trust (the \"Trust\") and has voting and dispositive power over the securities held by the Trust."}],"balance_after":22687,"source":{"system":"sec-edgar","filing":"0002143905-26-000003","document":"form4-08102026_100801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000214390526000003/form4-08102026_100801.xml","form_type":"4"}},{"id":691958,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25043,"kind":"person","name":"Liptak Vincent Paul","position":1,"cik":"0002143905","reported_name":"Liptak Vincent Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-10T22:26:05.000Z","date":"2026-08-10","kind":"purchase","planned":false,"acquired":true,"shares":2200,"price":16,"value":35200.0,"ownership":{"direct":true},"balance_after":111412,"source":{"system":"sec-edgar","filing":"0002143905-26-000003","document":"form4-08102026_100801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000214390526000003/form4-08102026_100801.xml","form_type":"4"}},{"id":691957,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25043,"kind":"person","name":"Liptak Vincent Paul","position":1,"cik":"0002143905","reported_name":"Liptak Vincent Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-08-10T22:26:05.000Z","date":"2026-08-07","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":15.8,"value":39500.0,"ownership":{"direct":true},"balance_after":109212,"source":{"system":"sec-edgar","filing":"0002143905-26-000003","document":"form4-08102026_100801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000214390526000003/form4-08102026_100801.xml","form_type":"4"}}]}